Clinicians treating obesity should screen for the presence of eating disorder psychopathology before prescribing GLP-1RAs, as these medications are contraindicated in cases of overweight or obesity associated with atypical anorexia nervosa, bulimia nervosa, and subthreshold bulimia nervosa
First, MedVi will have you fill out a short health questionnaire
Ameriprise and LPL Financial for the past few years have engaged in a financial advice trade war
Kalathil shares that, Agilent supports this critical need with GLP-compliant analytical workflows that help manufacturers validate materials, assess E&Ls, and meet global regulatory standards
It affects: How you get new patients How you screen and evaluate them How you document care How you order, stock, and track meds How you communicate with patients Patient Leads and Advertising The FDAs 2026 warning letters targeted clinics and telehealth companies for using phrases like same active ingredient as Ozempic, generic Zepbound, or from the same family as Mounjaro. If you've got anything like that on your website or in your ads, take it down
